HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever Q2

This article was originally published in The Rose Sheet

Executive Summary

Dove brand generated double-digit sales growth in North America during the second quarter, driven largely by new products, Unilever reports during Aug. 4 analyst call. Performance helped fuel high single-digit revenue growth in firm's U.S. Personal Care business, company notes. Worldwide Personal Care turnover was up 4.2% to $3.2 bil. (€1=$1.24), representing 5.6% underlying sales growth. Operating profit for the segment improved 4.7% at constant rates to $517.8 mil...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013260

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel